“Dupilumab Improves Disease Control and Patient-Reported Outcomes in Adults with Atopic Dermatitis in Clinical Practice: Subgroup Analysis of Black/African American Population from RELIEVE-AD”, J of Skin, vol. 8, no. 1, p. s327, Jan. 2024, doi: 10.25251/skin.8.supp.327.